Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling mtor signaling'

Search results for: 'research area pi3k akt signaling mtor signaling'

Items 31-40 of 109

Page
per page
  1. SB-505124 hydrochloride
    A3799 SB-505124 hydrochloride
    Target: ALK
    Summary: ALK5/ALK4/ALK7 inhibitor in TGF-β/activin signalling,selective
  2. TAK-632
    A8226 TAK-632
    Target: Raf
    Summary: Pan-RAF inhibitor,potent and selective
      ≥27.75 mg/mL
  3. GDC-0879
    A5071 GDC-0879
     1 Citation
    Target: Raf
    Summary: B-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL
  4. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
  5. LY2228820
    A5566 LY2228820
     1 Citation
    Target: p38
    Summary: P38 MAP kinase inhibitor
      ≥30.65 mg/mL
  6. Trametinib (GSK1120212)
    A3018 Trametinib (GSK1120212)
     7 Citation
    Target: MEK
    Summary: MEK1 and MEK2 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
  7. WP1066
    A4140 WP1066
    Target: STAT|JAK
    Summary: JAK2/STAT3 inhibitor,cell-permeable
      insoluble in H2O; ≥17.8 mg/mL
  8. Salinomycin
    A3785 Salinomycin
    Target: Antibiotic
    Summary: Polyether ionophore antibiotic;anti-cancer
  9. PLX-4720
    A3016 PLX-4720
     1 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥20.69 mg/mL
  10. PF-04691502
    A8499 PF-04691502
    Target: Akt|PI3K|mTOR
    Summary: PI3K/mTOR (FRAP) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.63 mg/mL

Items 31-40 of 109

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 107item
  2. Natural Products 1 item
  3. Protein 2item
  4. Peptides & Proteins 3item
Specificity
  1. Selective 58item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Akt 10item
  3. PI3K 22item
  4. Raf 6item
  5. Aurora Kinases 1 item
  6. mTOR 16item
  7. Androgen Receptors 1 item
  8. FLT3 1 item
  9. GSK-3 4item
  10. Eph Receptors 1 item
  11. VEGFR 5item
  12. PDGFR 2item
  13. Phosphodiesterases (PDEs) 1 item
  14. p38 4item
  15. PKB 1 item
  16. Bcr-Abl 1 item
  17. MEK 3item
  18. PORCN 1 item
  19. FGFR 1 item
  20. GABAB Receptors 1 item
  21. Src 1 item
  22. NMDA Receptors 1 item
  23. STAT 4item
  24. EGFR 2item
  25. JAK 3item
  26. DNA-PK 6item
  27. HSP90 1 item
  28. Toll-like receptors (TLRs) 1 item
  29. ERK 2item
  30. PKC 5item
  31. ALK 1 item
  32. PKG 1 item
  33. PKA 3item
  34. RSK 1 item
  35. ATM/ATR 2item
  36. Histamine H1 Receptors 1 item
  37. P110 1 item
  38. Hck 1 item
  39. NO Donors / Precursors 1 item
  40. IL Receptors 1 item
  41. AChE 1 item
  42. BACE 1 item
  43. p70 rsk 1 item
  44. sodium channels 1 item
  45. Smoothened receptor 1 item
  46. Nrf2/ARE signal 1 item
  47. PPAR 1 item
  48. Antibiotic 1 item
  49. Prk 1 item
  50. ICAM 1 item
  51. Rho 1 item
  52. Thrombin Receptor 1 item
  53. prolactin secretion 1 item
  54. gonadotropin release 1 item
  55. TRPC channel 1 item
  56. PKD 1 item
  57. FKBP 1 item
  58. ATM 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Cancer 1 item
  4. Breast Cancer 15item
  5. Cancer 58item
  6. Cervical Cancer 1 item
  7. Colon Cancer 6item
  8. Colorectal Cancer 6item
  9. Glioblastoma 9item
  10. Glioma 4item
  11. Heart Failure 1 item
  12. Leukemia 6item
  13. Liver Cancer 1 item
  14. Lung Cancer 4item
  15. Lymphoma 2item
  16. Melanoma 5item
  17. Multiple Myeloma 1 item
  18. Myeloma 1 item
  19. Neuroblastoma 1 item
  20. Non-small Cell Lung Cancer 4item
  21. Ovarian Cancer 5item
  22. Pancreatic Cancer 6item
  23. Pancreatic Carcinoma 1 item
  24. Prostate Cancer 7item
  25. Pulmonary Fibrosis 1 item
  26. Renal Cancer 1 item
  27. Rheumatoid Arthritis 2item
  28. Thyroid Cancer 2item
  29. Type 2 Diabetes 1 item